HF
BSTC

Hoxton Financial’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Hoxton Financial’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-51
Closed -$1K – 624
2013
Q4 		$1K Buy
+51
New +$1.04K ﹤0.01% 681

Other funds holding BSTC

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return

Hoxton Financial's BSTC Position: Q1 2014 in Review

Hoxton Financial sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2014, closing a stake of 51 shares — an estimated $1K sold.

Hoxton Financial first reported a position in BSTC in Q4 2013 and held it in 1 quarter. The position peaked at $1K in Q4 2013. 45 funds tracked by Wall St. Rank hold BSTC as of Q1 2014.

  • Hoxton Financial reported no remaining BioSpecifics Technologies Corp. position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 51 BioSpecifics Technologies Corp. shares in Q1 2014, an estimated $1K.
  • Hoxton Financial first reported a position in BioSpecifics Technologies Corp. in Q4 2013 and held it in 1 quarter.
  • Hoxton Financial's BioSpecifics Technologies Corp. position peaked at $1K in Q4 2013.
  • 45 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.